Last viewed: LLY

Prices are updated after-hours

LLY Nyse 2021 - 03 - 10

Eli Lilly and Company

LLY | News | $724.615 -1.04% 480K

|

Health Technology

(0.0% 1d) (-2.9% 1m) (99.9% 1y) (0.0% 2d) (1.8% 3d) (3.6% 7d) (NaN% volume)
Earnings Calendar: 2024-02-06
Market Cap: $ 688,503,414,386
http://www.lilly.com
Sec Filling | Patents | 33625 employees

(US) Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Drugs

Alimta (Pemetrexed disodium)
Amyvid (Florbetapir F 18)
Bamlanivimab (Bamlanivimab)
Baqsimi (glucagon)
BASAGLAR KwikPen (Insulin glargine)
BASAGLAR Tempo Pen (Insulin glargine)
Cialis (Tadalafil)
Cymbalta (Duloxetine hydrochloride)
CYRAMZA (ramucirumab)
Effient (Prasugrel hydrochloride)
EMGALITY (galcanezumab-gnlm)
Etesevimab (Etesevimab)
Evista (Raloxifene hydrochloride)
Forteo (Teriparatide)
Gemzar (Gemcitabine hydrochloride)
Glucagon (glucagon)
Humalog (Insulin lispro)
Humalog Junior KwikPen (Insulin lispro)
Humalog KwikPen (Insulin lispro)
Humalog Mix50/50 (Insulin lispro)
Humalog Mix50/50 KwikPen (Insulin lispro)
Humalog Mix75/25 (Insulin lispro)
Humalog Mix75/25 KwikPen (Insulin lispro)
Humalog Tempo Pen (Insulin lispro)
HUMATROPE (Somatropin)
Humulin 70/30 (Insulin human)
Humulin 70/30 KwikPen (Insulin human)
Humulin N (Insulin human)
Humulin R (Insulin human)
Humulin R U-500 (Insulin human)
Humulin R U-500 KwikPen (Insulin human)
Insulin Lispro (Insulin lispro)
Insulin Lispro Junior KwikPen (Insulin lispro)
Insulin Lispro KwikPen (Insulin lispro)
Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen (Insulin lispro)
LARTRUVO (olaratumab)
LYUMJEV (Insulin lispro-aabc)
LYUMJEV Junior KwikPen (Insulin lispro-aabc)
LYUMJEV KwikPen (Insulin lispro-aabc)
LYUMJEV Tempo Pen (Insulin lispro-aabc)
Olumiant (baricitinib)
Portrazza (necitumumab)
RETEVMO (selpercatinib)
Reyvow (lasmiditan)
Sterile Diluent (diluent)
Strattera (Atomoxetine hydrochloride)
Symbyax (Olanzapine and Fluoxetine hydrochloride)
TALTZ (ixekizumab)
TAUVID (Flortaucipir F-18)
Trulicity (Dulaglutide)
Verzenio (abemaciclib)
Zyprexa (Olanzapine)
ZYPREXA Intramuscular (Olanzapine)
ZYPREXA Relprevv (Olanzapine pamoate)
ZYPREXA Zydis (Olanzapine)

add to watch list Paper trade email alert is off

Press-releases

Top 5 Remote Regulatory Jobs
Published: 2024-04-25 (Crawled : 06:00) - biospace.com/
LLY | News | $724.615 -1.04% 480K

|

Health Technology

| 0.0% | O: -3.58% H: 0.0% C: 0.0%

[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
Published: 2024-04-24 (Crawled : 05:00) - globenewswire.com
LLY | News | $724.615 -1.04% 480K

|

Health Technology

| 1.78% | O: 1.78% H: 0.0% C: 0.0%
covid-19 sales first announcement growing roche

ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
Published: 2024-04-22 (Crawled : 21:00) - globenewswire.com
LLY | News | $724.615 -1.04% 480K

|

Health Technology

| 2.86% | O: 1.06% H: 0.0% C: 0.0%
PRQR | News | $1.84 -8.46% 56K

|

Health Technology

| 0.5% | O: 0.5% H: 5.47% C: 0.5%
meeting

Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $135.35 400

|

Health Technology

| 0.03% | O: 0.24% H: 0.42% C: 0.42%
NVO | News | $124.46 -1.35% 730K

|

Health Technology

| 1.31% | O: -0.84% H: 0.86% C: -0.62%
GSK | News | $40.93 0.17% 170K

|

Health Technology

| 3.18% | O: -0.56% H: 0.0% C: 0.0%
LLY | News | $724.615 -1.04% 480K

|

Health Technology

| 0.19% | O: -0.21% H: 0.11% C: -3.05%
AZN | News | $75.37 5.86% 2.7M

|

Health Technology

| 4.3% | O: -0.18% H: 0.84% C: 0.6%
report reach therapeutics market

89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
Published: 2024-04-17 (Crawled : 20:00) - globenewswire.com
SNYNF | News | $94.0 -0.27% 0

|

Health Technology

| 1.4% | O: 0.0% H: 0.0% C: 0.0%
SNY | News | $49.085 5.31% 1.2M

|

Health Technology

| 2.36% | O: -1.81% H: 0.0% C: 0.0%
biotech

Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity
Published: 2024-04-17 (Crawled : 11:00) - biospace.com/
LLY | News | $724.615 -1.04% 480K

|

Health Technology

| 0.1% | O: 1.03% H: 1.66% C: -1.11%
obesity tirzepatide

Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement
Published: 2024-04-16 (Crawled : 15:00) - biospace.com/
LLY | News | $724.615 -1.04% 480K

|

Health Technology

| 0.19% | O: 0.09% H: 0.0% C: 0.0%
announcement conference for financial results

CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
Published: 2024-04-15 (Crawled : 20:00) - globenewswire.com
CRGX | $18.69 -0.32% 60K

|

| -5.73% | O: -1.76% H: 6.0% C: 2.35%
LLY | News | $724.615 -1.04% 480K

|

Health Technology

| 0.19% | O: 0.09% H: 0.0% C: 0.0%
BDTX | $4.99 -1.38% 42K

|

Health Technology

| -3.07% | O: 0.57% H: 2.86% C: 2.48%
AUTL | $4.105 -2.49% 770K

|

Health Technology

| -14.08% | O: 0.0% H: 2.04% C: -0.82%
therapeutics

Usher Syndrome Market to Exhibit Growth at a CAGR of 10.55% by 2034 | DelveInsight
Published: 2024-04-11 (Crawled : 22:00) - prnewswire.com
ALPMF | News | $9.5 1.2K

|

Health Technology

| -8.21% | O: -100.0% H: NaN% C: Infinity%
ALPMY | News | $9.47 400K

|

| -7.97% | O: -8.65% H: 3.19% C: 1.6%
JNJ | News | $147.46 -0.72% 820K

|

Health Technology

| -1.7% | O: -1.65% H: 0.0% C: 0.0%
LLY | News | $724.615 -1.04% 480K

|

Health Technology

| -0.97% | O: -0.0% H: 0.52% C: -1.04%
growth market

Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
Published: 2024-04-11 (Crawled : 05:00) - globenewswire.com
LLY | News | $724.615 -1.04% 480K

|

Health Technology

| 0.05% | O: 1.06% H: 0.47% C: -0.03%
fda device disease test granted blood designation for alzheimer's roche

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0000059478-24-000082	4	2024-03-11	2024-02-12	Buy	A	186	186
0000059478-24-000082	4	2024-03-11	2024-02-12	Buy	A	184	184
0000059478-24-000082	4	2024-03-11	2024-03-11	Sell	S	750	7880
0000059478-24-000075	4	2024-02-21	2024-02-20	Buy	A	13	2098

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

45%

55%

Top 10 Gainers

SGBX | $0.26 80.43% 54M

|

Producer Manufacturing

LICN | $1.0 78.57% 3.3M

|

CSSE 4 | $0.2656 74.39% 9.7M

|

Consumer Services

BRFH 4 | $1.89 71.82% 32M

|

BOF | $1.95 66.67% 920K

|

MTC | $3.62 61.61% 790K

|

Technology Services

AMST | $3.13 56.5% 500K

|

Technology Services

PCSA | $2.28 40.74% 37M

|

Producer Manufacturing

EVA | $0.626 39.14% 2.3M

|

Process Industries

OPTN | $1.215 31.31% 12M

|

Health Services

Last 48 Hours Insiders Buying

MNSB P 1470 | $15.38 -3.21% 3.9K

|

| 12:00
RKT P 347 | $11.815 -5.86% 270K

|

| 22:30
NWFL | News | $24.21 55

|

| 22:00
TGEN P 10000 | $0.68 20K

|

| 20:01
RMCF | $3.51 -1.13% 20

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar